Company profile
AcuCort company profile
AcuCort’s vision is that Dexa ODF will be globally commercialized, be well integrated and used in the treatment/risk management of acute allergic reactions and croup in children, and see wide use against chemotherapy-induced nausea and vomiting (CINV.) AcuCort shall develop and commercialize Dexa ODF supported by a global network of licensees and/or distributors. AcuCort shall also identify, develop and commercialize complementary smart products with short time to launch that are based on existing substances. AcuCort AB was founded in 2006 as a subsidiary of DuoCort AB. 2011 marked a new beginning for AcuCort and its development project, as the life..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://acucort.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2006-01-01
Headquarters
- Headquarters
- Helsingborg, Skåne, Sweden
- Postal code
- 252 20
- Country code
- SE
- Continent
- Europe